tiprankstipranks
NervGen Pharma (TSE:NGEN)
:NGEN
Canadian Market

NervGen Pharma (NGEN) Income Statement

Compare
35 Followers

NervGen Pharma Income Statement

Last quarter (Q3 2024), NervGen Pharma's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, NervGen Pharma's net income was C$-5.23M. See NervGen Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -145.00KC$ -115.11KC$ -42.63KC$ -39.65KC$ -38.22K
Operating Expenses
C$ 17.78MC$ 23.03MC$ 12.81MC$ 11.20MC$ 9.86M
Depreciation and Amortization
C$ 145.00KC$ 115.11KC$ 42.63KC$ 39.65KC$ 38.22K
EBITDA
C$ -17.72MC$ -20.09MC$ -12.77MC$ -11.16MC$ -9.83M
Operating Income
C$ -17.78MC$ -22.82MC$ -12.87MC$ -11.19MC$ -9.86M
Other Income/Expenses
C$ -4.61MC$ 2.30MC$ 84.65KC$ 9.74KC$ 98.83K
Pretax Income
C$ -22.38MC$ -20.72MC$ -12.73MC$ -11.19MC$ -9.77M
Net Income
C$ -22.38MC$ -18.11MC$ -12.64MC$ -11.18MC$ -9.67M
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -0.38C$ -0.34C$ -0.32C$ -0.35C$ -0.37
Diluted EPS
C$ -0.38C$ -0.34C$ -0.32C$ -0.35C$ -0.37
Weighted Average Shares Outstanding
59.29M 52.65M 39.29M 32.11M 25.90M
Weighted Average Shares Outstanding (Diluted)
59.29M 52.65M 39.29M 32.11M 25.90M
Currency in CAD

NervGen Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis